Position in GPCR
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,325,628
-$53,861 QoQ
Shares Held
43,332
-12.2% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#82
of 191 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANQUE PICTET & CIE SA holds $213,407,213 across 8 Biotechnology names. GPCR ranks #4 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
2,699,402 | $189,039,122 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,496 | $11,671,168 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
44,736 | $2,600,503 | |
| 4 | GPCR |
Structure Therapeutics Inc.
This page
|
43,332 | $2,325,628 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,713 | $2,315,204 | |
| 6 | IMVT |
Immunovant, Inc.
|
57,190 | $2,203,530 | |
| 7 | BNTX |
BioNTech SE
|
17,705 | $1,647,450 | |
| 8 | AVIR |
Atea Pharmaceuticals, Inc.
|
345,077 | $1,604,608 |
All Filings in GPCR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,325,628 | 43,332 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,379,489 | 49,367 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $4,164,723 | 59,881 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $1,797,180 | 64,185 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,460,116 | 70,401 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $1,415,369 | 81,766 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,011,680 | 74,177 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $3,557,416 | 81,053 | Shares | Sole | 2024-10-21 | |
| No filing history on record for this holder in this stock. | ||||||